Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Morenzo Abadi Perkasa Tbk. (ENZO) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Morenzo Abadi Perkasa Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Morenzo Abadi Perkasa Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Morenzo Abadi Perkasa Tbk. trades at Rp75 (market cap 160.03B, 5.25M 24h volume), while UBC Medical Indonesia Tbk. trades at Rp168 (market cap 651.75B, 848.2K 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 4.1× Morenzo Abadi Perkasa Tbk.'s market cap, and Morenzo Abadi Perkasa Tbk. is more actively traded (5.25M versus 848.2K). Which is the better fit depends on your goals.

ENZOLABS
Market Cap
160.03B651.75B
Volume
5.25M848.2K
Lot
52.53K8.48K
Turnover
388.03M140.51M
Average Price
73.87165.66
Value
388.03M140.51M
Indicative Equilibrium Price
75168
Indicative Equilibrium Volume
71750

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ENZO
View details
LABS
View details

About Morenzo Abadi Perkasa Tbk.

PT Morenzo Abadi Perkasa Tbk, (The “Company”) was established based on Notarial Deed No. 21 of Jhon Langsung, S.H., dated January 10, 2013. Company commenced its commercial business activities in 2013. PT Tritunggal Sukses Investama is the ultimate Parent Entity and Parent Entity of the Company and Mr. Markus Silitonga as the ultimate shareholder.

Read more on ENZO

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS